EU MDR Certification Timeline
This page summarizes the typical timelines for obtaining CE marking certification under the EU Medical Device Regulation (EU) 2017/745 (MDR).
Notified Body Assessment Timelines
Based on the 20th European Commission Notified Body Survey (data up to February 2026):
QMS Certificate Only
| Timeline Range | Percentage of Notified Bodies |
|---|---|
| 6-12 months | 30% |
| 13-18 months | 62% (most common) |
| 19-24 months | 8% |
QMS + Product Certificate (Combined)
| Timeline Range | Percentage of Notified Bodies |
|---|---|
| 6-12 months | ~18% |
| 13-18 months | 51% (most common) |
| 19-24 months | 31% |
New EU Maximum Timeline Rules (Effective February 25, 2027)
The EU Implementing Regulation on uniform procedural requirements establishes maximum timelines:
| Activity | Maximum Timeline |
|---|---|
| Application review & contract signing | 30 days |
| QMS audit | 120 days |
| Product verification (technical documentation) | 90 days |
| Decision & certificate issuance | 20 days |
| Total maximum (new applications) | ~260 days (~8.7 months) |
Note: These maximums apply to contracts signed after February 25, 2027.
Total Estimated Timeline (End-to-End)
| Phase | Typical Duration |
|---|---|
| Regulatory strategy & gap analysis | 1-3 months |
| Technical documentation preparation | 3-12 months |
| Clinical evaluation / PMCF plan | 2-6 months |
| Notified Body application & contract | 1-3 months |
| QMS audit (Stage 1 + Stage 2) | 2-4 months |
| Technical documentation review | 3-6 months |
| Additional information responses | 1-6 months |
| Certificate issuance | <1 month |
| Total estimated range | 13-24 months |
Risk Class Impact
| Device Class | Route | Typical NB Involvement |
|---|---|---|
| Class I | Self-declaration | No NB required (except sterile/measuring) |
| Class IIa | Annex IX or XI | QMS audit + product sampling |
| Class IIb | Annex IX or X+XI | Full QMS + technical documentation review |
| Class III | Annex IX + Annex X | Full QMS + full product assessment + clinical scrutiny for implantables |
Key Factors Affecting Timeline
- Submission quality — Only 14/51 NB report >50% complete submissions at initial review
- Clinical data — PMCF requirements and clinical investigation add 6-18 months
- NB capacity — Limited NB availability creates queue times (improving with 51 designated NBs by 2026)
- Classification changes — Up-classification under MDR vs. MDD adds documentation burden
Last updated: July 2026
Sources: European Commission 20th NB Survey (March 2026), EU Implementing Regulation 2026/XX on uniform procedural requirements